Comparison of the sensitivity of commercial strains and infant isolates of bifidobacteria to antibiotics and bacteriocins

Abstract

Eighteen bifidobacteria, six isolated from infant feces and 12 commercial strains (of which 10 were purchased from the American Type Culture Collection), were tested for sensitivity to 14 antibiotics and four bacteriocins including nisin A, nisin Z, pediocin PA-1 and mutacin B-Ny266. All bacteria were resistant to vancomycin, kanamycin, neomycin and streptomycin. Infant isolates were more sensitive than commercial strains to cloxacillin, ampicillin, chloramphenicol, tetracycline, rifampicin and novobiocin. Sensitivity to bacteriocins determined by a microplate assay varied widely. Generally, nisin A was the most effective bacteriocin followed by nisin Z and mutacin B-Ny266. Pediocin PA-1 appeared to have no inhibition at 70 μg mL⁻¹. Commercial strains showed relatively variable sensitivity to bacteriocins compared to infant isolates, which were inhibited within a narrow range of bacteriocin concentration. Bacteriocin tolerance could be easily gained by prolonging the exposure time. Death–time curves and transmission electron microscopy (TEM) of logarithmic and stationary cells of two strains (Bifidobacterium adolescentis ATCC 15704 and infant isolate Bifidobacterium sp. RBL67) incubated with twice the minimum inhibitory concentration of nisin A and nisin Z for 3 h revealed that log-phase cells were more sensitive than stationary-phase cells. TEM showed that the cell membrane is the most likely site of bactericidal effects of nisin.